| Boehringer Ingelheim (Schweiz) GmbH - Glyxambi 10 mg / 5 mg, Filmtabletten | | 66132 | | 01 | | Glyxambi 10 mg / 5 mg | | Filmtabletten | | A10BD19 | | Linagliptin and Empagliflozin | | 29.03.2017 | | |
| | Composition | | empagliflozinum 10 mg, linagliptinum 5 mg, mannitolum, amylum pregelificatum, maydis amylum, copovidonum, crospovidonum, talcum, magnesii stearas, Überzug: hypromellosum, mannitolum, talcum, E 171, macrogolum 6000, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Empagliflozinum | 10 mg | | Linagliptinum | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Empagliflozinum | 10 mg | | Linagliptinum | 5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Amylum Pregelificatum | | | | Copovidonum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 6000 | | | Magnesii Stearas | | | | Mannitol | | | | Maydis Amylum | | | | Pro Compresso Obducto | | | | Talcum | | |
| |
| |
|
